May 2003
Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
Apr   Jun


For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.


C H A N N E L S
PULSE Home Page
EXECUTIVE EDITION

US News
Canada News
UK News
New Zealand News

Consumer Advocacy
Health Care Systems
Managed Care/Medicaid
Co-occurring Disorders
Clinical studies
Pharmaceutical News
Criminal Justice Systems
Legislative News


U S E R ' S   G U I D E
About PULSE
PULSE Channels

Archives

Adding comments

Using the # link

Items that require registration

PULSE syndication

Tips for Searching PULSE


E M A I L   S U B S C R I P T I O N S

For WEEKLY summaries of PULSE postings, see the weekly email subscription form.

For DAILY mailings (powered by Bloglet), please enter your e-mail address below:


P U B L I C A T I O N S

PULSE ANNUAL No. 2
January 2003

Recent Trends, Challenges and Issues in Funding Public Mental Health Services in the US
March 2002

PULSE ANNUAL No. 1
October 2001

 

PULSE is powered by
Radio Userland
.

Listed on BlogShares

© Bill Davis, 2000-2003.

About PULSE | Channels | User's Guide | Email subscriptions | Publications




PULSE is a free service of the Centre for Community Change International, gathering new and noteworthy Internet resources for mental health providers, family members of individuals with mental illness, consumers of mental health services and consumer advocates. PULSE is researched, edited and designed by Bill Davis.



daily link  Monday, May 19, 2003


Antipsychotics and Bipolar Disorder
The most recent "Bipolar Disorders Expert Column Series" in Medscape Psychiatry & Mental Health - "New generation, or atypical, antipsychotics -- medications that were initially developed for the treatment of psychosis in general and schizophrenia in particular -- are being used increasingly in the treatment of bipolar disease. Medications such as olanzapine, which has a formal indication for bipolar disease from the US Food and Drug Administration, clozapine, quetiapine, and risperidone have become important tools for the clinician in helping to stabilize acutely ill bipolar patients and preventing them from becoming ill again. These medications may have efficacy beyond being simply antimanic agents, but may have utility as true mood stabilizers; they may actually help prevent mood fluctuations that interfere with social and occupational functioning...." [Viewing Medscape resources requires registration, which is free].  
permalink  


Researchers Identify New Variety of Dementia
NewsRx story at PsycPORT on research presented at the annual American Academy of Neurology meeting by researchers at the University of Florida who "believe they have identified a new form of dementia, a disease that develops mostly in elderly people and is characterized by a progressive, generally irreversible loss of mental capabilities."  
permalink  


Some success seen with depression treatment by phone
Health Behavior News Service story - "Phone calls can help primary care doctors and nurses deliver follow-up care to patients who are depressed, a new study suggests. Three months after enrolling in a disease management program offered by telephone, patients with acute depression were six times more likely to have their symptoms reduced to a low level than those who received the standard care of diagnosis and education about their condition."  
permalink